Ormetoprim structure
|
Common Name | Ormetoprim | ||
|---|---|---|---|---|
| CAS Number | 6981-18-6 | Molecular Weight | 274.318 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 398.2±52.0 °C at 760 mmHg | |
| Molecular Formula | C14H18N4O2 | Melting Point | 233°C | |
| MSDS | N/A | Flash Point | 194.6±30.7 °C | |
Use of OrmetoprimOrmetoprim is a veterinary antimicrobial which commonly used in aquaculture and poultry industries. Ormetoprim can be used to prevent the spread of disease in freshwater aquaculture and promote growth in farm animals[1][2]. |
| Name | 5-[(4,5-dimethoxy-2-methylphenyl)methyl]pyrimidine-2,4-diamine |
|---|---|
| Synonym | More Synonyms |
| Description | Ormetoprim is a veterinary antimicrobial which commonly used in aquaculture and poultry industries. Ormetoprim can be used to prevent the spread of disease in freshwater aquaculture and promote growth in farm animals[1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | Ormetoprim (8.3 mg/kg; i.p.) exhibits absorption half-life (5.4 h), elimination half-life (7.5 h) and Cmax (1.2±0.2 μg/mL)[3]. Ormetoprim (8.3 mg/kg; p.o.) exhibits absorption half-life (3.9 h), elimination half-life (3.9 h), Cmax (1.6±0.4 μg/mL) and oral availability (78.5%) relative to intraperitoneal administration[3]. Animal Model: Hybrid striped bass (565-805 g)[3] Dosage: 50 mg/kg Sulfadimethoxine and Ormetoprim in a 5:1 ratio (Pharmacokinetic Analysis) Administration: I.p. and p.o. administration Result: I.p.: t1/2(elim)=7.5 h; t1/2(abs)=5.4 h; Cmax=1.2 μg/mL. P.o.: t1/2(elim)=3.9 h; t1/2(abs)=3.9 h; Cmax=1.6 μg/mL; F=78.5%. |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 398.2±52.0 °C at 760 mmHg |
| Melting Point | 233°C |
| Molecular Formula | C14H18N4O2 |
| Molecular Weight | 274.318 |
| Flash Point | 194.6±30.7 °C |
| Exact Mass | 274.142975 |
| PSA | 96.28000 |
| LogP | 1.13 |
| Vapour Pressure | 0.0±0.9 mmHg at 25°C |
| Index of Refraction | 1.608 |
| Storage condition | 0-6°C |
|
~%
Ormetoprim CAS#:6981-18-6 |
| Literature: US2007/49609 A1, ; Page/Page column 83 ; US 20070049609 A1 |
|
~%
Ormetoprim CAS#:6981-18-6 |
| Literature: US2005/209260 A1, ; Page/Page column 89 ; |
|
~60%
Ormetoprim CAS#:6981-18-6 |
| Literature: Manchand, Percy S.; Rosen, Perry; Belica, Peter S.; Oliva, Gloria V.; Perrotta, Agostino V.; Wong, Harry S. Journal of Organic Chemistry, 1992 , vol. 57, # 13 p. 3531 - 3535 |
|
~%
Ormetoprim CAS#:6981-18-6 |
| Literature: Journal of Organic Chemistry, , vol. 57, # 13 p. 3531 - 3535 |
|
~%
Ormetoprim CAS#:6981-18-6 |
| Literature: Journal of Organic Chemistry, , vol. 57, # 13 p. 3531 - 3535 |
|
~%
Ormetoprim CAS#:6981-18-6 |
| Literature: Journal of Organic Chemistry, , vol. 57, # 13 p. 3531 - 3535 |
|
~%
Ormetoprim CAS#:6981-18-6 |
| Literature: Journal of Organic Chemistry, , vol. 57, # 13 p. 3531 - 3535 |
|
~%
Ormetoprim CAS#:6981-18-6 |
| Literature: Journal of Organic Chemistry, , vol. 57, # 13 p. 3531 - 3535 |
| Precursor 10 | |
|---|---|
| DownStream 0 | |
| UNII-M3EFS94984 |
| 5-((4,5-Dimethoxy-2-methylphenyl)methyl)-2,4-pyrimidinediamine |
| Ro 5-9754 |
| component of Rofenaid |
| Ormetoprim |
| EINECS 230-246-6 |
| MFCD00057747 |
| 2,4-Pyrimidinediamine, 5-[(4,5-dimethoxy-2-methylphenyl)methyl]- |
| 5-(4,5-Dimethoxy-2-methylbenzyl)-2,4(1H,3H)-pyrimidinediimine |
| 5-(4,5-Dimethoxy-2-methylbenzyl)pyrimidine-2,4-diamine |
| 2,4(1H,3H)-Pyrimidinediimine, 5-[(4,5-dimethoxy-2-methylphenyl)methyl]- |
| 5-(4,5-Dimethoxy-2-methylbenzyl)-2,4-pyrimidinediamine |
| Ormethoprim |
| Ormetorprim |